Premium
Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole‐brain radiotherapy, and local ocular therapy
Author(s) -
Taoka Kazuki,
Yamamoto Go,
Kaburaki Toshikatsu,
Takahashi Tsuyoshi,
Araie Makoto,
Kurokawa Mineo
Publication year - 2012
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2011.08938.x
Subject(s) - medicine , intraocular lymphoma , procarbazine , lymphoma , radiation therapy , primary central nervous system lymphoma , vincristine , methotrexate , chop , chemotherapy , rituximab , surgery , cyclophosphamide
published_or_final_versionSpringer Open Choice, 25 May 201